No Data
No Data
Express News | March 4 noon announcement: Inteltech plans to build a new complete equipment project with an annual output of 1,000 sets of evaporative condensers
Renhe Pharmaceutical (000650.SZ) subsidiary obtained the drug registration certificate for sodium hyaluronate eye drops
Renhe Pharmaceutical (000650.SZ) issued an announcement. The company's subsidiary Jiangxi Shanliang Pharmaceutical Co., Ltd. recently received the national...
Renhe Pharmaceutical (000650.SZ): 1.00% of shares have been cumulatively repurchased
Gelonghui on March 1, 丨 Renhe Pharmaceutical (000650.SZ) announced that as of February 29, 2024, the company had repurchased 14,000,000 shares of the company's shares through a dedicated securities account, accounting for 1.00% of the company's current total share capital (1,399,938,234 shares). The highest transaction price of the repurchase was 6.78 yuan/share, and the minimum transaction price was RMB 5.18 yuan/share, and the total transaction amount was RMB 90,3236 million (excluding transaction fees).
Renhe Pharmaceutical (000650.SZ): A total cost of 806.18,400 yuan to buy back 12.3 million shares
Gelonghui, February 1, 丨 Renhe Pharmaceutical (000650.SZ) announced that as of January 31, 2024, the company had repurchased a total of 12.3 million shares of the company's shares through a special stock repurchase account, accounting for 0.8786% of the company's current total share capital. The highest transaction price for the repurchase was 6.78 yuan/share, the minimum transaction price was 5.76 yuan/share, and the total amount paid was 806.184,000 yuan (excluding transaction fees).
Renhe Pharmaceutical (000650.SZ): A total cost of 6.0723 million yuan to buy back 9 million shares
Gelonghui, January 2, 丨 Renhe Pharmaceutical (000650.SZ) announced that as of December 31, 2023, the company had repurchased 9 million shares of the company's shares through a special stock repurchase securities account, accounting for 0.6429% of the company's current total share capital. The highest transaction price for the repurchase was 6.78 yuan/share, the minimum transaction price was 6.40 yuan/share, and the total amount paid was 6.723 million yuan (excluding transaction fees).
Renhe Pharmaceutical (000650.SZ): The company's cold medicine sales are normal
Gelonghui December 18丨Renhe Pharmaceutical (000650.SZ) said on the investor interactive platform that the company's cold medicine sales are normal. Judging from Ren Colic's data for the first three quarters of 2023, revenue increased 97% year on year.
No Data